Psilocybin Research Resources

Psilocybin is being studied around the world in fields like mental health, neurology, and beyond. On this page, we have compiled a list of trusted sources that follow the science as it evolves. All our content is shared solely for legal, academic, and ethically responsible exploration.

Studies and Research Databases

MAPS LINK
MAPS (Multidisciplinary Association for Psychedelic Studies) are one of the oldest and most respected organisations backing psychedelic research in the world. They are a not-for-profit that funds, designs and oversees clinical studies on the use of psychedelics.
Psychedelic Alpha covers the more expansive psychedelic space, including clinical trials, legal developments, and intellectual property. It’s a trusted source for following how psilocybin is being researched, regulated, and understood worldwide.
Blossom is one of the largest databases of psychedelic research. It’s fully searchable by compound, condition, and trial stage, making it an excellent resource for exploring the clinical science behind psilocybin.
Psilocybin-Research.com offers accessible, science-based summaries on how psilocybin affects the brain, consciousness, and mental health. It’s a good starting point for anyone new to the topic.

Universities & Clinical Trials

Johns Hopkins University runs one of the world’s most respected centres for psychedelic research. Their clinical trials with psilocybin have shown promising results in treating depression, addiction, and anxiety, helping bring psychedelic science into the medical mainstream.
Imperial College London runs the UK’s leading centre for psychedelic science. Their research into psilocybin for depression, anxiety, and brain function has shaped global understanding and helped bring psychedelic therapy into serious medical discussion.
UCSF is conducting some of the world’s most advanced psilocybin trials for both mental health and neurological conditions. Their clinical work is medically rigorous, exploring how psilocybin could help with depression, Parkinson’s, chronic pain, and more.
Sheppard Pratt is one of the first major mental health institutions to explore psilocybin therapy for treatment-resistant depression and suicidal ideation. They focus on safety, integration, and real-world outcomes.